当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析 - 现金流量表

沃森生物

(300142)

  

流通市值:214.27亿  总市值:217.19亿
流通股本:15.78亿   总股本:15.99亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,127,515,644.26441,691,381.882,608,820,008.551,771,029,194
  收到的税费返还--6,958,581.516,947,105.18
  收到其他与经营活动有关的现金52,004,986.7827,216,907.66173,137,841.9172,075,640.86
  经营活动现金流入小计1,179,520,631.04468,908,289.542,788,916,431.971,850,051,940.04
  购买商品、接受劳务支付的现金638,552,340.55302,965,750.731,719,060,891.191,338,841,211.27
  支付给职工以及为职工支付的现金213,563,711.65124,192,531.74351,293,078.4272,877,806.58
  支付的各项税费89,022,419.0734,284,138.45138,407,899.7797,197,320.02
  支付其他与经营活动有关的现金64,464,872.7827,704,921.6689,228,396.4561,443,512.41
  经营活动现金流出小计1,005,603,344.05489,147,342.582,297,990,265.811,770,359,850.28
  经营活动产生的现金流量净额173,917,286.99-20,239,053.04490,926,166.1679,692,089.76
二、投资活动产生的现金流量:
  收回投资收到的现金10,297,692.086,661,283.13188,751,283.69158,285,591.07
  取得投资收益收到的现金--3,444,383.943,444,383.94
  处置固定资产、无形资产和其他长期资产收回的现金净额50,349.83-699,903.18192,715
  收到的其他与投资活动有关的现金311,401,207.19---
  投资活动现金流入小计321,749,249.16,661,283.13192,895,570.81161,922,690.01
  购建固定资产、无形资产和其他长期资产支付的现金161,691,440.2994,889,103.18509,544,939.65357,253,150.1
  投资支付的现金193,500,00050,000,000--
  支付其他与投资活动有关的现金11,401,207.19---
  投资活动现金流出小计366,592,647.48144,889,103.18509,544,939.65357,253,150.1
  投资活动产生的现金流量净额-44,843,398.38-138,227,820.05-316,649,368.84-195,330,460.09
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,702,5002,440,000
  其中:子公司吸收少数股东投资收到的现金--2,702,5002,440,000
  取得借款收到的现金1,122,404,834.83952,570,000159,000,000-
  收到其他与筹资活动有关的现金74,690,053.1324,690,053.13144,098,105.75-
  筹资活动现金流入小计1,197,094,887.96977,260,053.13305,800,605.752,440,000
  偿还债务支付的现金120,296,654.4-393,694,507.64232,993,145.44
  分配股利、利润或偿付利息支付的现金263,923,824.4354,459,702.96789,862,333.69788,889,566.3
  其中:子公司支付给少数股东的股利、利润--760,868,500760,868,500
  支付其他与筹资活动有关的现金1,524,003,567.471,145,806,224.041,706,427,438.87947,982,701.17
  筹资活动现金流出小计1,908,224,046.31,200,265,9272,889,984,280.21,969,865,412.91
  筹资活动产生的现金流量净额-711,129,158.34-223,005,873.87-2,584,183,674.45-1,967,425,412.91
四、汇率变动对现金及现金等价物的影响-3,215,886.35-1,147,114.85-951,793.34908,358.77
五、现金及现金等价物净增加额-585,271,156.08-382,619,861.81-2,410,858,670.47-2,082,155,424.47
  加:期初现金及现金等价物余额1,348,244,145.541,348,244,145.543,759,102,816.013,759,102,816.01
  期末现金及现金等价物余额762,972,989.46965,624,283.731,348,244,145.541,676,947,391.54
补充资料:
  净利润45,939,173.56-125,157,091.43-
  资产减值准备-68,218,942.13-251,664,603.63-
  固定资产和投资性房地产折旧114,632,252.43-261,911,123.09-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧114,632,252.43-261,911,123.09-
  无形资产摊销53,115,418.33-119,364,342.7-
  长期待摊费用摊销8,719,602.36-19,665,557.34-
  处置固定资产、无形资产和其他长期资产的损失-351,321.33--81,071.48-
  固定资产报废损失232,701.44-1,011,398.04-
  公允价值变动损失58,734,900--29,676,000-
  财务费用8,308,429.96--20,919,436.84-
  投资损失429,568.1--2,554,430.79-
  递延所得税552,953.22--15,513,603.88-
  其中:递延所得税资产减少3,688,704.69--6,253,912.1-
    递延所得税负债增加-3,135,751.47--9,259,691.78-
  存货的减少-39,181,867.61-162,932,645.67-
  经营性应收项目的减少137,748,365.67-111,912,551.74-
  经营性应付项目的增加-151,055,376.77--504,759,687.96-
  现金的期末余额762,972,989.46-1,348,244,145.54-
  减:现金的期初余额1,348,244,145.54-3,759,102,816.01-
  现金及现金等价物的净增加额-585,271,156.08--2,410,858,670.47-
公告日期2026-08-292026-04-282026-03-282025-10-29
审计意见(境内)标准无保留意见
TOP↑